basq2 ccb2
Name
bgnd2
Label
Biguanides (SHHS2)
Description

Participant taking BIGUANIDES within two weeks of the SHHS2 visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
Type
choices
Tags
BGND2 diabetes
Biguanides (SHHS2) vs SHHS Visit Number
Visit 1 Interim Follow-up Visit Visit 2 CVD Outcomes
Total - - 4,080 -
No - - 3,461 -
Yes - - 159 -
Unknown - - 460 -
Biguanides (SHHS2) vs Gender
Visit 2
Male Female Total
Total 1,861 2,219 4,080
No 1,580 1,881 3,461
Yes 81 78 159
Unknown 200 260 460
Biguanides (SHHS2) vs Race
Visit 2
White Black Other Total
Total 3,587 256 237 4,080
No 3,034 227 200 3,461
Yes 128 15 16 159
Unknown 425 14 21 460